Pilot Controlled Clinical Trial of Salvia Officinalis (Sage) for cognitive impairments in Parkinson's Disease
- Conditions
- Cognitive impairment in Parkinson's Disease
- Registration Number
- EUCTR2007-002899-34-GB
- Lead Sponsor
- ewcastle Upon tyne Hospitals NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
parkinson's disease, mild cognitive impairment (mmse >24 and mattis dementia rating scale <10)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Dementia according to DSM IV-R. active psychosis. clinically significant depression. use of cholinesterase inhibitors. uncontrolled hypertension.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To determineif sage significantly reduces cognitive impairment in people with Parkinson's disease compared to vitamin E;Secondary Objective: ;Primary end point(s): CDR tests of quality and speeds of memory and power of attention
- Secondary Outcome Measures
Name Time Method